Lindman, Henrik, et al. “Individually Tailored Toxicity-Based 5-Fluorouracil, Epirubicin and Cyclophosphamide (FEC) Therapy of Metastatic Breast Cancer”. Acta Oncologica, vol. 46, no. 2, Jan. 2007, pp. 165-71, doi:10.1080/02841860600871087.